| pubmed-article:2979050 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2979050 | lifeskim:mentions | umls-concept:C0205095 | lld:lifeskim |
| pubmed-article:2979050 | lifeskim:mentions | umls-concept:C0021888 | lld:lifeskim |
| pubmed-article:2979050 | lifeskim:mentions | umls-concept:C0027599 | lld:lifeskim |
| pubmed-article:2979050 | lifeskim:mentions | umls-concept:C0048038 | lld:lifeskim |
| pubmed-article:2979050 | lifeskim:mentions | umls-concept:C1280519 | lld:lifeskim |
| pubmed-article:2979050 | lifeskim:mentions | umls-concept:C1609285 | lld:lifeskim |
| pubmed-article:2979050 | lifeskim:mentions | umls-concept:C1292733 | lld:lifeskim |
| pubmed-article:2979050 | pubmed:dateCreated | 1989-6-30 | lld:pubmed |
| pubmed-article:2979050 | pubmed:abstractText | Apraclonidine (para-aminoclonidine) is an alpha agonist that was studied for its effect on the IOP rise following YPC. In a prospective multicentered double-masked study 63 eyes were pretreated with one drop of either 1% apraclonidine or placebo 1 hour prior to performing YAG and again after the laser treatment. The greatest IOP rise in the placebo-treated eyes occurred in the third hour after YPC when the mean IOP rose from a baseline pressure of 16.4 +/- 3.7 mm Hg to 20.8 +/- 6.8 mm Hg (P less than .01). In apraclonidine-treated eyes the IOP fell from a mean of 15.6 +/- 3.8 mm Hg to 12.8 +/- 6.0 mm Hg 3 hours postoperatively (P less than .001). There were five times as many eyes that had a pressure rise greater than 10 mm Hg in the placebo-treated group compared to those treated with apraclonidine. Apraclonidine proved to be highly effective in preventing the rise in IOP following YPC. | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2979050 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2979050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2979050 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2979050 | pubmed:issn | 0065-9533 | lld:pubmed |
| pubmed-article:2979050 | pubmed:author | pubmed-author:WhiteG LGL | lld:pubmed |
| pubmed-article:2979050 | pubmed:author | pubmed-author:StewartR HRH | lld:pubmed |
| pubmed-article:2979050 | pubmed:author | pubmed-author:PollackI PIP | lld:pubmed |
| pubmed-article:2979050 | pubmed:author | pubmed-author:BrownR HRH | lld:pubmed |
| pubmed-article:2979050 | pubmed:author | pubmed-author:RobinA LAL | lld:pubmed |
| pubmed-article:2979050 | pubmed:author | pubmed-author:CrandallA SAS | lld:pubmed |
| pubmed-article:2979050 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2979050 | pubmed:volume | 86 | lld:pubmed |
| pubmed-article:2979050 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2979050 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2979050 | pubmed:pagination | 461-72 | lld:pubmed |
| pubmed-article:2979050 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:2979050 | pubmed:meshHeading | pubmed-meshheading:2979050-... | lld:pubmed |
| pubmed-article:2979050 | pubmed:meshHeading | pubmed-meshheading:2979050-... | lld:pubmed |
| pubmed-article:2979050 | pubmed:meshHeading | pubmed-meshheading:2979050-... | lld:pubmed |
| pubmed-article:2979050 | pubmed:meshHeading | pubmed-meshheading:2979050-... | lld:pubmed |
| pubmed-article:2979050 | pubmed:meshHeading | pubmed-meshheading:2979050-... | lld:pubmed |
| pubmed-article:2979050 | pubmed:meshHeading | pubmed-meshheading:2979050-... | lld:pubmed |
| pubmed-article:2979050 | pubmed:meshHeading | pubmed-meshheading:2979050-... | lld:pubmed |
| pubmed-article:2979050 | pubmed:meshHeading | pubmed-meshheading:2979050-... | lld:pubmed |
| pubmed-article:2979050 | pubmed:meshHeading | pubmed-meshheading:2979050-... | lld:pubmed |
| pubmed-article:2979050 | pubmed:meshHeading | pubmed-meshheading:2979050-... | lld:pubmed |
| pubmed-article:2979050 | pubmed:meshHeading | pubmed-meshheading:2979050-... | lld:pubmed |
| pubmed-article:2979050 | pubmed:meshHeading | pubmed-meshheading:2979050-... | lld:pubmed |
| pubmed-article:2979050 | pubmed:meshHeading | pubmed-meshheading:2979050-... | lld:pubmed |
| pubmed-article:2979050 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:2979050 | pubmed:articleTitle | Effectiveness of apraclonidine in preventing the rise in intraocular pressure after neodymium:YAG posterior capsulotomy. | lld:pubmed |
| pubmed-article:2979050 | pubmed:affiliation | Wilmer Ophthalmology Institute, Department of Ophthalmology, Johns Hopkins University, Baltimore. | lld:pubmed |
| pubmed-article:2979050 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2979050 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:2979050 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:2979050 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
